ClinicalTrials.Veeva

Menu

Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes

B

Baqiyatallah Medical Sciences University

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Treatments

Drug: Routine treatment
Drug: Vitamin D3

Study type

Interventional

Funder types

Other

Identifiers

NCT04439474
IR.BMSU.REC.1392.32

Details and patient eligibility

About

This study looked at the effect of vitamin D levels on the complications of type 2 diabetes and the fat profile of patients with diabetes.Participants in this study were divided into two groups. One group included participants with vitamin D deficiency and the other group did not.The first group receives 50,000 units of oral vitamin D 3 daily for up to 8 days.

Enrollment

187 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with type 2 diabetes
  • Having conscious satisfaction

Exclusion criteria

  • Patients with a history of gastrointestinal surgery
  • Patients with a history of renal failure
  • Patients with a history of vitamin D intake and calcium-containing compounds
  • Patients with a history of liver disease

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

187 participants in 2 patient groups

Patients with vitamin D deficiency
Experimental group
Description:
This group receives 50,000 units of vitamin D3 daily for up to 8 days until the serum level of vitamin D reaches above 30 ng/ml.
Treatment:
Drug: Vitamin D3
Patients without vitamin D deficiency
Active Comparator group
Description:
Participants in this group receive only their usual treatments
Treatment:
Drug: Routine treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems